0001062993-23-020120.txt : 20231103
0001062993-23-020120.hdr.sgml : 20231103
20231103183533
ACCESSION NUMBER: 0001062993-23-020120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231101
FILED AS OF DATE: 20231103
DATE AS OF CHANGE: 20231103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Geist William
CENTRAL INDEX KEY: 0001832210
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 231377718
MAIL ADDRESS:
STREET 1: 900 MIDDLESEX TURNPIKE
STREET 2: C/O QUANTERIX CORPORATION
CITY: BILLERICA
STATE: MA
ZIP: 01821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-11-01
0000842023
BIO-TECHNE Corp
TECH
0001832210
Geist William
614 MCKINLEY PL NE
MINNEAPOLIS
MN
55413
0
1
0
0
PRESIDENT, PROTEIN SCIENCES
0
Common Stock
9960
D
Restricted Stock Units
Common Stock
3360
3360
D
Stock Options (Right to Buy)
100.39
2029-02-01
Common Stock
11936
11936
D
Stock Options (Right to Buy)
100.39
2029-02-01
Common Stock
15912
15912
D
Restricted Stock Units
Common Stock
7140
7140
D
Stock Options (Right to Buy)
94.52
2029-08-15
Common Stock
22200
22200
D
Stock Options (Right to Buy)
94.52
2029-08-15
Common Stock
29600
29600
D
Restricted Stock Units
Common Stock
8377
8377
D
Stock Options (Right to Buy)
84.61
2030-08-15
Common Stock
22544
22544
D
Stock Options (Right to Buy)
84.61
2030-08-15
Common Stock
30059
30059
D
Restricted Stock Units
2023-11-01
4
A
0
19857
0
A
Common Stock
19857
19857
D
Includes 6,640 shares of restricted stock for which the risk of forfeiture will lapse as to 3,320 shares on each of 2/1/2024 and 2/1/2025.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2024 and options to purchase 3,976 shares vest on each of 2/1/2025 and 2/1/2026.
Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.
9,929 restricted stock units vest on 11/1/2024 and 9,928 restricted stock units vest on 11/1/2025.
/s/ Andrew Nick as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed
2023-11-03